Inactive Instrument

All News Unigene Laboratories Inc

Equities

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Unigene Laboratories Inc : Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update	14/13/14	PU
Unigene Laboratories Inc : Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs	09/13/09	PU
Unigene Laboratories Inc : Victory Park Capital Completes Public Auction of Unigene’s Peptelligence™ Drug Delivery Platform	18/13/18	PU
Unigene Laboratories : Unigene Secures Financing to Extend Operating Runway in Conjunction with Strategic Reorganization – Victory Park Capital Commences Process for Potential Sale of PeptelligenceTM Drug Delivery Platform	08/13/08	PU
Unigene Laboratories Inc : Unigene Announces Fourth Quarter and Full-Year 2012 Results	12/13/12	PU
Unigene Laboratories Inc : Unigene Comments on FDA Advisory Committee Review of Salmon Calcitonin	07/13/07	PU
Unigene Laboratories Inc : UNIGENE RECEIVES 2013 DRUG DELIVERY PARTNERSHIPS	13/13/13	PU
Unigene Laboratories Inc : Unigene to Present at the 17th Annual Drug Delivery Partnerships Meeting	07/13/07	PU
Unigene Laboratories Inc : Unigene Completes Financial Statement Amendment	01/13/01	PU
Unigene Laboratories Inc : Unigene Welcomes FDA Advisory Committee Review of Salmon Calcitonin	15/13/15	PU
Unigene Laboratories Inc : Unigene’s Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone	12/12/12	PU
Unigene Laboratories Inc : Unigene Engages Financial Advisor to Explore Strategic Options and Advance Corporate Objectives	11/12/11	PU
Unigene Laboratories Inc : UNIGENE AND TARIX PHARMACEUTICALS ENTER DEFINITIVE LICENSING AGREEMENT FOR “PEPTELLIGENCE-ENGINEERED” TXA127	27/12/27	PU
Unigene Laboratories Inc : Unigene Announces Third Quarter 2012 Corporate Update	20/12/20	PU
Unigene Laboratories Inc : Unigene to Announce Third Quarter 2012 Financial Results on November 20, 2012	16/12/16	PU
Unigene Laboratories : Unigene’s Licensee, Tarsa Therapeutics, Reports Positive Clinical Data in Phase 2 Study of Oral Calcitonin for Prevention of Postmenopausal Osteoporosis	16/12/16	PU
Unigene Laboratories : Unigene to Target Partnering and Therapeutic Development Opportunities Following Victory Park Capital Debt Financing and Forbearance	26/12/26	PU
Unigene Laboratories : UNIGENE AND TARIX PHARMACEUTICALS REPORT HIGHLY INCREASED ORAL BIOAVAILABILITY OF “PEPTELLIGENCE-ENGINEERED” TXA127	19/12/19	PU
Unigene Laboratories : UNIGENE AND NORDIC BIOSCIENCE ANNOUNCE PRELIMINARY SELECTION OF LEAD COMPOUND FOR TREATING TYPE 2 DIABETES	15/12/15	PU
Unigene Laboratories : Unigene Enters Agreement to Eliminate 1/3 of its Outstanding $67MM Debt	04/12/04	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Unigene Laboratories Inc

Equities

All News

Filters